Health-care company stocks declined. Moderna shares fell after reports that federal health officials are re-evaluating its $590 million contract to help develop a bird-flu vaccine. Shares of Teladoc ...
Nvidia reports better-than-expected fourth-quarter earnings as revenue jumps 78% on demand for the company’s ...
The Dow, S&P 500, and Nasdaq fell Thursday as the stock market digested Nvidia earnings and Trump's latest tariff threats.
Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...
The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.
Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...
Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future.
Nvidia is helping to prop up the U.S. stock market, and indexes are drifting higher. The S&P 500 rose 0.4% in early Thursday ...
U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna ( NASDAQ: MRNA) by the ...
American pharmaceutical company Moderna (MRNA) is reportedly under scrutiny by U.S. President Donald Trump’s team, which is ...
US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results